The role of cetuximab in the treatment of metastatic colorectal cancer.
about
Trial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapyImmune biomarkers of anti-EGFR monoclonal antibody therapyRegorafenib effects on human colon carcinoma xenografts monitored by dynamic contrast-enhanced computed tomography with immunohistochemical validationCorrelation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation.Mechanisms of resistance to EGFR targeted therapies.Personalized oncology in interventional radiology.Cetuximab intensifies the ADCC activity of adoptive NK cells in a nude mouse colorectal cancer xenograft model.
P2860
Q26745686-ACCC7FBD-AA5E-4A4A-B764-575EFCFAF55DQ34723594-D65A3864-9F7B-4A35-B372-425810E2CCDFQ35010176-0DB7C21E-ABA3-4F70-80AA-3F1E73F928C7Q35068706-DBC93146-07D4-47E3-B97C-006AB3E83D8CQ36887721-DDB6158A-5B1B-4A08-AFBC-CB430B780997Q37092371-4B45D0E2-EAA0-4D52-BC50-258A8E2AA90CQ37204600-BC45116E-CC8F-4461-B2B1-784E7ED555CF
P2860
The role of cetuximab in the treatment of metastatic colorectal cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The role of cetuximab in the treatment of metastatic colorectal cancer.
@en
type
label
The role of cetuximab in the treatment of metastatic colorectal cancer.
@en
prefLabel
The role of cetuximab in the treatment of metastatic colorectal cancer.
@en
P2093
P1433
P1476
The role of cetuximab in the treatment of metastatic colorectal cancer.
@en
P2093
Jana Dreslerova
Jindrich Finek
Lubos Holubec
Ondrej Fiala
Petra Mrazkova
Vaclav Liska
Vit M Matejka
Vladislav Treska
P304
P407
P577
2012-09-01T00:00:00Z